However, given the clear distinction in ApoE4 presence between AD and non-AD groups, a dichotomous classification (ApoEε4 carrier vs. non-carrier) may provide a more robust and clinically interpretable measure. The gene discussed is APOE; the disease is Alzheimer disease.